secwatch.observer — SEC 8-K summary
======================================

Issuer:     Theriva Biologics, Inc. (TOVX)
CIK:        0000894158
Form:       8-K
Filed at:   2025-10-17T23:59:59+00:00
Accession:  0001104659-25-100468
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Theriva (TOVX) raises ~$4.4M via warrant exercise at $0.54/share; grants 16.2M new warrants
--------------------------------------------------------------------------------

- Entered warrant inducement with existing holders exercising 8,092,280 shares at $0.54 for ~$4.4M gross proceeds.
- Issued new warrants for 16,184,560 shares (200% of exercised) at same $0.54 exercise price, exercisable 5 years from stockholder approval.
- Net proceeds will be used for working capital; AGP served as financial advisor with 7% cash fee.
- New warrants and underlying shares issued in private placement under Section 4(a)(2); resale registration to be filed within 30 days.
- Company must seek stockholder approval for exercise of new warrants; meetings every 60 days if not obtained.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/894158/000110465925100468/0001104659-25-100468-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/894158/000110465925100468/tm2528131d2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-100468

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer